Categories: Technology Facts

IBM has built a new drug-making lab entirely in the cloudKaren Haoon August 28, 2020 at 4:27 pm

The news: IBM has built a new chemistry lab called RoboRXN in the cloud. It combines AI models, a cloud computing platform, and robots to help scientists design and synthesize new molecules while working from home.

How it works: The online lab platform allows scientists to log on through a web browser. On a blank canvas, they draw the skeletal structure of the molecular compounds they want to make, and the platform uses machine learning to predict the ingredients required and the order in which they should be mixed. It then sends the instructions to a robot in a remote lab to execute. Once the experiment is done, the platform sends a report to the scientists with the results.

A screenshot of IBM's RoboRXN platform, which lets scientists draw the skeletal structure of the molecular compounds they want to make.A screenshot of IBM's RoboRXN platform, which lets scientists draw the skeletal structure of the molecular compounds they want to make.
The online platform lets scientists draw the skeletal structure of the molecular compounds they want to make.
IBM RESEARCH

Why it matters: New drugs and materials traditionally require an average of 10 years and $10 million to discover and bring to market. Much of that time is taken up by the laborious repetition of experiments to synthesize new compounds and learn from trial and error. IBM hopes that a platform like RoboRXN could dramatically speed up that process by predicting the recipes for compounds and automating experiments. In theory, it would lower the costs of drug development and allow scientists to react faster to health crises like the current pandemic, in which social distancing requirements have caused slowdowns in lab work.

Not alone: IBM is not the only one hoping to use AI and robotics to accelerate chemical synthesis. A number of academic labs and startups are also working toward the same goal. But the concept of allowing users to submit molecules remotely and receive analysis on the synthesized molecule is a valuable addition of IBM’s platform, says Jill Becker, the CEO of one startup, Kebotix: “With RoboRXN, IBM takes an important step to speed up discovery.”

Read More

Recent Posts

10 Quick Easy Ways to Make Money Online Now

Discover practical quick easy ways to make money online and offline. Explore freelance gigs, selling…

3 hours ago

Three of the Main Reasons To Use CBD Oil to Help You Get a Restful Night’s Sleep

When it comes to getting a good night’s sleep, it can often be tricky to…

6 hours ago

Boosting Online Visibility: The Role of Genuine Link Building

Table of Contents: Introduction to Link Building The Importance of Quality Links Techniques for Successful…

6 hours ago

Analyzing the risks and opportunities of investing in Bitcoin against the US dollar

In recent years, the transaction of bitcoin to usd dollar has attracted the attention of…

1 day ago

Top 10 Surprising Facts About Bhutan You Probably Didn’t Know

Tucked away in the folds of the Himalayas, the Kingdom of Bhutan remains one of…

1 day ago

How Custom Matchboxes Add A Touch Of Class To Your Brand Events?

In the current competitive market, the development of a memorable brand experience extends beyond the…

1 day ago